Why is Retatrutide's glucagon receptor agonism not counterproductive for glucose research
For glycemic control in patients with type 2 diabetes, less frequent dosing may lead to deterioration in blood glucose management
I think the expanding indications, the fact that were not just using these for diabetes, theyre for weight, theyre for the liver, theyre for sleep apnea
Clinical trials show the mix produces average weight loss of 25% of total body weight compared to 15-17% with semaglutide 2.4mg alone representing about 22 pounds of more weight loss for a 240-pound personal
8 L cells in the gastrointestinal tract sense the presence of nutrients in the gut lumen during feeding and secrete GLP-1 to act on multiple tissues, including the pancreas, intestines, and brain
Administering medications via the parenteral route may be useful when the medication is poorly absorbed orally, when immediate onset or delayed onset is required, or if the patient is unable to tolerate oral administration of medications